For citations:

Popova EV. Ofatumumab – the first fully human monoclonal antibody approved for the treatment of multiple sclerosis. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(6):142-145. (In Russ.) https://doi.org/10.14412/2074-2711-2023-6-142-145